Tade Matthias Spranger
Editorial
In their fundamental overview on intellectual property
and biotechnology, Victoria Jimenez and Dennis Fernandez not only deal
with the top-10 most common intellectual property rights mistakes during venture
capital due diligence, but also present a basic analysis of IP strategy in
biotech. The article also discusses IP problems related to genomics, proteomics,
pharmacogenomics, bioinformatics, biochips, and, last but not least, emerging
technologies such as nanotechnology or biogenerics, and therefore provides an
ideal tool for all those who are interested in the role of intellectual property
in the field of biotech.
Journal of International Biotechnology Law, Walter de Gruyter
Print ISSN: 1612-6068
Volume: 2, 11/2005
Pages: II - II
Show full article (external site)
Show all available items of this journal
Search
